Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
about
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data reviewThe Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewMood stabilizers in pregnancy and lactationValproate in the treatment of epilepsy in girls and women of childbearing potentialEpilepsy during pregnancy: focus on management strategiesTopiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Antiepileptic drugs in women with epilepsy during pregnancySafety of antiobesity drugs.Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsantsTopiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.Clinical pharmacology of topiramate in migraine prevention.Teratogenic effects of antiepileptic drugsNew pharmacological approaches for obesity management.Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice.Management of diabetes across the course of disease: minimizing obesity-associated complicationsHuman teratogens update 2011: can we ensure safety during pregnancy?Use of topiramate in pregnancy and risk of oral clefts.Are newer antiepileptic drugs associated with improved safety in pregnancy compared to older antiepileptic drugs?AED Treatment Through Different Ages: As Our Brains Change, Should Our Drug Choices Also?Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.Topiramate: safety and efficacy of its use in the prevention and treatment of migraine.Epilepsy drugs and effects on fetal development: Potential mechanisms.Effects of in utero antiepileptic drug exposureA pregnant pause to consider teratogenicity of topiramate.Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?The use of central nervous system active drugs during pregnancy.Neurological teratogenic effects of antiepileptic drugs during pregnancy.Teratogenicity and hyperprolactinemia.Antiepileptic drug use in women of childbearing age.Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate.Clinical psychopharmacology of eating disorders: a research update.Neurobehavioral consequences of prenatal antiepileptic drug exposure.Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.Treating epilepsy in pregnant women.Safety of topiramate for treating migraines.Pharmacological treatment and therapeutic perspectives of metabolic syndrome.New molecular targets in the pathophysiology of obesity and available treatment options under investigation.Managing Migraine During Pregnancy and Lactation.
P2860
Q24186683-96482D6B-1A61-4976-9E25-A0D5C14FAE61Q26741366-C6C5103F-86EF-49E0-B117-ABCB663EF12DQ26795394-6BA570AF-7023-431A-989C-FB7D4547F28EQ26865670-928F388F-BA3E-4604-9BEF-3228C93EED50Q28080299-627DC566-7FE0-4768-8050-A9BE23F20BD1Q31147165-D217A093-3D96-4E5D-88AB-84CA6FE7B3BAQ33949402-2D04C508-EC54-425C-A648-252296A088C8Q34016243-23437279-7DB5-49D6-B320-386AFAFAC721Q34147151-EAEA9EF3-9B12-478D-868A-1E281A25F845Q34180705-CFA5AAEF-E93A-47E4-A604-530E6F2AD382Q34200361-A3571E94-D559-4220-8AA9-A7F231CB5353Q34267151-5BDC4483-D9E3-4731-BB32-D962786D1637Q34349850-ECB66F16-9D59-4A18-96FD-94D660560EC9Q34544208-781AF045-4926-4E31-9307-1BAA7FB5D714Q34905287-AD7F86B2-96C3-46F8-863C-24DDDE021FDCQ35096627-BCF9822D-EC4C-4E55-851F-F11CB50AA017Q35574560-6D772A4C-A878-4815-B07C-DF81935B2A21Q35815011-4AEBBFC7-58A4-44BE-A74E-CA96FF7140CBQ36356810-D96A4978-2DA6-4C7B-B102-D069CEF7CFF3Q36623339-673D0053-17F9-493E-A703-85319FB7A950Q36656367-ED8EB071-D0E4-4A14-A64D-B590234666AFQ36766224-B0EF0987-DCCB-44ED-9DE2-5DB234F1621EQ36873926-2C5DF208-7FDE-4471-ACA4-A9E0856DA4DAQ36969393-2D0F268B-3F4C-41D1-B8EC-59F0B1D1C3EEQ37029076-19573FE2-4631-4120-930E-24EB69308722Q37169760-A0A7BF3C-6D1C-439C-B82D-3F0E937AD185Q37186130-A22EEF6B-EB10-4B18-AC14-804CB53B2F7FQ37280003-DCA436D0-D22D-48CC-A765-EE855DF610B9Q37287941-33F57CD0-B698-41A9-8EE1-8DC37B99EDBBQ37334220-3847937B-326A-47D1-8371-56B81E566AB9Q37341158-3E1F52C7-219E-410F-8148-2B664B90DC95Q37589010-A69A8D55-4749-4B7E-8F09-8D3CB27C6B79Q37857919-355917CF-4A94-4D95-88AA-9B0166C66CE1Q37980247-B11C3A21-7D97-4375-BECC-D97EB95B7D1EQ38014890-E816454A-BD37-443A-ACCC-E6F5B6F6FF8AQ38194574-B2A8AE48-7BEC-4167-9ABB-09B3A75F5CF8Q38237259-153ABE28-1BBE-44ED-8639-8A9DBE2302C3Q38262435-26D9391C-A0A9-47CC-B56C-09C177DBB24EQ38397535-84ECF3C2-19FF-407F-9C27-F7C3EDCED077Q38784408-33F10BDF-587E-4C45-B9CA-D87AEB151C57
P2860
Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@ast
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@en
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@nl
type
label
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@ast
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@en
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@nl
prefLabel
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@ast
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@en
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@nl
P2093
P1433
P1476
Topiramate in pregnancy: preli ...... ilepsy and Pregnancy Register.
@en
P2093
I Robertson
P J Morrison
UK Epilepsy and Pregnancy Register
P304
P356
10.1212/01.WNL.0000318293.28278.33
P407
P577
2008-07-01T00:00:00Z